155 related articles for article (PubMed ID: 23819639)
21. Lack of associations between XPC polymorphisms and colorectal cancer: a meta-analysis.
Wang G; Sun H; Liu Z; Huang R; Chen Y; Tang Q; Yu L; Jiang Z; Wang X
J BUON; 2015; 20(3):770-4. PubMed ID: 26214629
[TBL] [Abstract][Full Text] [Related]
22. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
He J; Shi TY; Zhu ML; Wang MY; Li QX; Wei QY
Int J Cancer; 2013 Oct; 133(8):1765-75. PubMed ID: 23400628
[TBL] [Abstract][Full Text] [Related]
23. Association of XPC polymorphisms and lung cancer risk: a meta-analysis.
Jin B; Dong Y; Zhang X; Wang H; Han B
PLoS One; 2014; 9(4):e93937. PubMed ID: 24736739
[TBL] [Abstract][Full Text] [Related]
24. Lack of association between XPC Lys939Gln polymorphism and prostate cancer risk: an updated meta-analysis based on 3039 cases and 3253 controls.
Wu H; Lv Z; Wang X; Zhang L; Mo N
Int J Clin Exp Med; 2015; 8(10):17959-67. PubMed ID: 26770390
[TBL] [Abstract][Full Text] [Related]
25. A meta-analysis of XPC Lys939Gln polymorphism and melanoma susceptibility.
Jiang W; Zhang H; Chen QW; Xie S
J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1327-31. PubMed ID: 26551988
[TBL] [Abstract][Full Text] [Related]
26. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.
Liu Y; Wang H; Lin T; Wei Q; Zhi Y; Yuan F; Song B; Yang J; Chen Z
Oncol Rep; 2012 Jul; 28(1):337-45. PubMed ID: 22505326
[TBL] [Abstract][Full Text] [Related]
27. Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai.
Wen H; Ding Q; Fang ZJ; Xia GW; Fang J
Int Urol Nephrol; 2009 Dec; 41(4):855-64. PubMed ID: 19350405
[TBL] [Abstract][Full Text] [Related]
28. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
29. The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis.
Yan Y; Liang H; Li T; Li M; Li R; Qin X; Li S
Tumour Biol; 2014 Apr; 35(4):3047-52. PubMed ID: 24390660
[TBL] [Abstract][Full Text] [Related]
30. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
[TBL] [Abstract][Full Text] [Related]
31. Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.
Qin X; Peng Q; Qin A; Chen Z; Lin L; Deng Y; Xie L; Xu J; Li H; Li T; Li S; Zhao J
Diagn Pathol; 2012 Oct; 7():136. PubMed ID: 23039364
[TBL] [Abstract][Full Text] [Related]
32. Genetic variants of DNA repair gene XPC modulating susceptibility to cervical cancer in North India.
Gangwar R; Mittal B; Srivastava S; Singh H; Mittal RD
Oncol Res; 2010; 18(7):329-35. PubMed ID: 20377134
[TBL] [Abstract][Full Text] [Related]
33. [Association of XPC gene polymorphisms with breast cancer risk].
Wu YY; Ma XY; Yao KY; Li QL; Chen K
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 May; 40(3):252-8. PubMed ID: 21671483
[TBL] [Abstract][Full Text] [Related]
34. The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies.
Yang S; Jin T; Su HX; Zhu JH; Wang DW; Zhu SJ; Li S; He J; Chen YH
PLoS One; 2015; 10(1):e0116500. PubMed ID: 25602258
[TBL] [Abstract][Full Text] [Related]
35. Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
Yang X; Liu D; Wu H; Kang H; Pang H; Huang D; Sha X; Wang E; Wang Z; Wei M
Cancer Sci; 2012 Jul; 103(7):1207-14. PubMed ID: 22519360
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in XPC gene and risk for prostate cancer.
Said R; Bougatef K; Setti Boubaker N; Jenni R; Derouiche A; Chebil M; Ouerhani S
Mol Biol Rep; 2019 Feb; 46(1):1117-1125. PubMed ID: 30552616
[TBL] [Abstract][Full Text] [Related]
37. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z
Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293
[TBL] [Abstract][Full Text] [Related]
38. Association of XPC gene polymorphisms with susceptibility to prostate cancer: evidence from 3,936 subjects.
Zou YF; Tao JH; Ye QL; Pan HF; Pan FM; Su H; Ye DQ
Genet Test Mol Biomarkers; 2013 Dec; 17(12):926-31. PubMed ID: 24093803
[TBL] [Abstract][Full Text] [Related]
39. Genetic Association between the XPG Asp1104His Polymorphism and Head and Neck Cancer Susceptibility: Evidence Based on a Meta-Analysis.
Jiang HY; Zeng Y; Xu WD; Liu C; Wang YJ; Wang YD; Wang YD
Asian Pac J Cancer Prev; 2015; 16(9):3645-51. PubMed ID: 25987016
[TBL] [Abstract][Full Text] [Related]
40. An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis.
Ji C; Liu Z; Chen H; Guo H; Liu C
BMC Cancer; 2012 Aug; 12():335. PubMed ID: 22857644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
